As shown in Fig. 5C, significantly increased recruitment of Smad2/3 to the regulatory regions of Osx was observed in OCCM-30 cells treated for 1 day with OM, compared with untreated cells. The gene discussed is SMAD2; the disease is ocular melanoma.